De MOL - Regnier Pharma SRL
1.6 FTEDe MOL - Regnier Pharma reported total assets of 642,568 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026), with 1.6 full-time equivalent.
The score of De MOL - Regnier Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +46 % Total assets -17 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
De MOL - Regnier Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 44,991 € | ||||
| Equity | 314,817 € | ||||
| Cash | 120,159 € | ||||
| EBITDA | 121,489 € | ||||
| Total assets | 642,568 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 30 Jun 2021filed on 08 Feb 2022
De MOL - Regnier Pharma's financial analysis
- Solvency49.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of De MOL - Regnier Pharma
De MOL - Regnier Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0897.726.486
- VAT number
- BE0897726486
- Peppol
- Registered · 0208:0897726486 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 May 2008
- Registered office
- 6180 Courcelles
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
De MOL - Regnier Pharma (SRL) has been based in Courcelles since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 44,991 € and equity of 314,817 €; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 49.0%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to De MOL - Regnier Pharma
Companies in the same business, of comparable size and area, outside its group.
- Axcofarma Retail sale of pharmaceutical products Diepenbeek · balance sheet 489,172 €
- Pharmacie du Sacre - Coeur Retail sale of pharmaceutical products Tournai · balance sheet €1.00m
- Wenduine Pharma Retail sale of pharmaceutical products De Haan · balance sheet €1.25m
- Apotheek Boits Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 705,427 €
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- B.D. Farma Retail sale of pharmaceutical products Zwalm · balance sheet 562,484 €
- Smart Pharma Retail sale of pharmaceutical products Ixelles · balance sheet 483,477 €
- Regatta Pharma Retail sale of pharmaceutical products Stekene · balance sheet 593,302 €
Frequently asked questions about De MOL - Regnier Pharma
What is the revenue of De MOL - Regnier Pharma?
De MOL - Regnier Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of De MOL - Regnier Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0897726486 for De MOL - Regnier Pharma, if the company is VAT-registered. Its company number (CBE) is 0897.726.486.
Where is the registered office of De MOL - Regnier Pharma?
According to the CBE register, the registered office of De MOL - Regnier Pharma is in 6180 Courcelles.
What is the equity of De MOL - Regnier Pharma?
At the close of the 2025 financial year, the equity of De MOL - Regnier Pharma amounts to 314,817 €, a solvency of 49.0% of total assets.
How many people work at De MOL - Regnier Pharma?
1.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages De MOL - Regnier Pharma?
The register lists 3 active mandates at De MOL - Regnier Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of De MOL - Regnier Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →